Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
IRE1α is a central sensor and mediator of the unfolded protein response (UPR), activated by misfolded proteins in the ER. It is a bifunctional enzyme with serine/threonine-protein kinase and endoribonuclease activity. Upon sensing ER stress, IRE1α oligomerizes, autophosphorylates, and activates its RNase domain, leading to XBP1 mRNA splicing (producing XBP1s, a transcription factor) and regulated IRE1-dependent decay (RIDD) of specific mRNAs. It is implicated in neurodegenerative diseases and cancer and considered a promising drug target for diseases involving chronic ER stress.
Kinase/RNase inhibition (small molecule inhibitors)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Inositol-requiring enzyme 1 alpha (IRE1α).